The following government grants in the FederalGrants.com database contain the term housing in the listing.
Grants are sorted newest to oldest. Select a grant title to view the complete details, including information on who to contact and how to apply.
| Grant Title | CFDA | Funding Number |
| Alzheimer's Disease Initiative - Specialized Supportive Services (ADI-SSS) Project Financed Solely by 2018 Prevention and Public Health Funds (PPHF 2018) |
93.763 |
HHS-2018-ACL-AOA-ALGG-0284 |
| Administrative Supplements for Participation in the Concept to Clinic: Commercializing Innovation (C3i) Program (Admin Supp - Clinical Trial Not Allowed) |
93.242, 93.286, 93.847, 93.853, 93.865 |
PA-18-702 |
| Innovative Basic Research on Adducts in Cancer Risk Identification and Prevention (R21 Clinical Trial Not Allowed) |
93.113, 93.393, 93.394, 93.395 |
PAR-18-703 |
| Selective Cell and Network Vulnerability in Aging and Alzheimers Disease (R01 - Clinical Trial Not Allowed) |
93.866 |
PAR-18-706 |
| Innovative Basic Research on Adducts in Cancer Risk Identification and Prevention (R01 Clinical Trial Not Allowed) |
93.113, 93.393, 93.394, 93.395 |
PAR-18-704 |
| NEI Translational Research Program (TRP) on Therapy for Visual Disorders (R24 Clinical Trial Optional) |
93.867 |
PAR-18-707 |
| NIDCD Research Dissertation Fellowship for Au.D. Audiologists (F32) (Clinical Trials Not Allowed) |
93.173 |
PA-18-700 |
| Science-Based Quality Measurement and Management Development for Opioid Use Disorder Treatment (R61/R33 Clinical Trial Required) |
93.279 |
RFA-DA-19-005 |
| Basic and Translational Oral Health Research Related to HIV/AIDS (R21 Clinical Trial Not Allowed) |
93.121 |
PA-18-695 |
| Stimulating T4 Implementation Research to Optimize Integration of Proven-effective Interventions for Heart, Lung, and Blood Diseases and Sleep Disorders into Practice (STIMULATE) (R01 Clinical Trial Not Allowed) |
93.233, 93.837, 93.838, 93.839, 93.840 |
RFA-HL-19-014 |
| Natural Product, Multi-Site, Clinical Trial, Data Coordinating Center (Collaborative U24 - Clinical Trial Required) |
93.213 |
PAR-18-697 |
| Advanced Laboratories for Accelerating the Reach and Impact of Treatments for Youth and Adults with Mental Illness (ALACRITY) Research Centers (P50 Clinical Trial Optional) |
93.242 |
PAR-18-701 |
| NIJ FY18 Programs and Services for Victims of Crime: Phased Evaluation Research |
16.560 |
NIJ-2018-14060 |
| High Priority HIV/AIDS Research within the Mission of the NIDDK (R01 Clinical Trial Optional) |
93.847 |
PAS-18-698 |
| Basic and Translational Oral Health Research Related to HIV/AIDS (R01 Clinical Trial Not Allowed) |
93.121 |
PA-18-699 |
| Clinical Coordinating Center for NCCIH Multi-Site Investigator-Initiated Clinical Trials of Natural Products (Collaborative UG3/UH3 Clinical Trial Required) |
93.213 |
PAR-18-696 |
| Reproductive Scientist Development Program (RSDP) (K12 Clinical Trial Not Allowed) |
93.865 |
RFA-HD-18-103 |
| Short-term Mentored Career Enhancement Awards for Mid-Career Investigators to Integrate Basic Behavioral and Social Sciences (K18 Clinical Trial Required) |
93.173, 93.213, 93.399, 93.866 |
PAR-18-692 |
| BRAIN Initiative: New Concepts and Early - Stage Research for Large - Scale Recording and Modulation in the Nervous System (R21) (Clinical Trial Not Allowed) |
93.173, 93.213, 93.242, 93.273, 93.279, 93.286, 93.853, 93.865, 93.866, 93.867 |
RFA-EY-18-001 |
| Interdisciplinary Research Teams to Investigate Reciprocal Basic Behavioral and Social Linkages Between Sleep and Stress (R24 Clinical Trial Optional) |
93.273, 93.846 |
PAR-18-694 |
| Center without Walls for PET Ligand Development for Alzheimer's disease related dementias (ADRDs) (U19 Clinical Trial Optional) |
93.853, 93.866 |
RFA-NS-18-025 |
| Grants for Adaptive Sports Programs for Disabled Veterans and Disabled Members of the Armed Forces |
64.034 |
VA-ASG-2019-01 |
| Developmental Pharmacodynamics and Models of Drug Effects in Pediatrics (R01 Clinical Trial Optional) |
93.865 |
PA-18-688 |
| Innovative Therapies and Tools for Screenable Disorders (R21 Clinical Trial Optional) |
93.350, 93.865 |
PAR-18-691 |
| Innovative Therapies and Tools for Screenable Disorders (R03 Clinical Trial Optional) |
93.350, 93.865 |
PAR-18-690 |
| Innovative Therapies and Tools for Screenable Disorders (R01 Clinical Trial Optional) |
93.350, 93.853, 93.865 |
PAR-18-689 |
| Developmental Pharmacodynamics and Models of Drug Effects in Pediatrics (R03 Clinical Trial Optional) |
93.865 |
PA-18-687 |
| NINDS Postdoctoral Mentored Career Development Award (K01 Clinical Trial Required) |
93.853 |
PAR-18-685 |
| NINDS Postdoctoral Mentored Career Development Award (K01 No Independent Clinical Trial Allowed) |
93.853 |
PAR-18-686 |
| NHLBI Early Phase Clinical Trials for Therapeutics and/or Diagnostics (R61/R33 Clinical Trial Required) |
93.233, 93.837, 93.838, 93.839 |
PAR-18-683 |
| Fundamental Mechanisms of Affective and Decisional Processes in Cancer Control (R01 Clinical Trial Optional) |
93.393 |
PAR-18-681 |
| NHLBI Early Phase Clinical Trials for Therapeutics and/or Diagnostics (R33 Clinical Trial Required) |
93.233, 93.837, 93.838, 93.839 |
PAR-18-684 |
| Service Area Competition-Additional Areas (SAC-AA) - Anchorage, Alaska; Sarasota, Florida; and Perth Amboy, New Jersey |
93.224 |
HRSA-18-109 |
| Announcement for Program Funding for NRCS' Conservation Innovation Grants (CIG) for Federal fiscal year (FY) 2018 - Pennsylvania |
10.912 |
USDA-NRCS-PA-CIG-18-001 |
| NIAID Physician-Scientist Pathway to Independence Award (K99/R00 Clinical Trial Required) |
93.855 |
PAR-18-679 |
| Epidemiologic Research on Emerging Risk Factors and Liver Cancer Susceptibility (R01 - Clinical Trial Not Allowed) |
93.393 |
PA-18-677 |
| Epidemiologic Research on Emerging Risk Factors and Liver Cancer Susceptibility (R21 - Clinical Trial Not Allowed) |
93.393 |
PA-18-678 |
| 2018 Evidence-Based Falls Prevention Program financed by Prevention and Public Health Fund |
93.761 |
HHS-2018-ACL-AOA-FPSG-0255 |
| 2018 Empowering Older Adults and Adults with Disabilities through Chronic Disease Self-Management Education Programs Financed by the Prevention and Public Health Fund |
93.734 |
HHS-2018-ACL-AOA-CSSG-0256 |
| Identify, Analyze, and Evaluate Potential Risk Factors for Amyotrophic Lateral Sclerosis (ALS) |
93.061 |
RFA-TS-18-001 |
Search Results 6441-6480 of 17636
[Prev] 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60 61 62 63 64 65 66 67 68 69 70 71 72 73 74 75 76 77 78 79 80 81 82 83 84 85 86 87 88 89 90 91 92 93 94 95 96 97 98 99 100 101 102 103 104 105 106 107 108 109 110 111 112 113 114 115 116 117 118 119 120 121 122 123 124 125 126 127 128 129 130 131 132 133 134 135 136 137 138 139 140 141 142 143 144 145 146 147 148 149 150 151 152 153 154 155 156 157 158 159 160 161 162 163 164 165 166 167 168 169 170 171 172 173 174 175 176 177 178 179 180 181 182 183 184 185 186 187 188 189 190 191 192 193 194 195 196 197 198 199 200 201 202 203 204 205 206 207 208 209 210 211 212 213 214 215 216 217 218 219 220 221 222 223 224 225 226 227 228 229 230 231 232 233 234 235 236 237 238 239 240 241 242 243 244 245 246 247 248 249 250 251 252 253 254 255 256 257 258 259 260 261 262 263 264 265 266 267 268 269 270 271 272 273 274 275 276 277 278 279 280 281 282 283 284 285 286 287 288 289 290 291 292 293 294 295 296 297 298 299 300 301 302 303 304 305 306 307 308 309 310 311 312 313 314 315 316 317 318 319 320 321 322 323 324 325 326 327 328 329 330 331 332 333 334 335 336 337 338 339 340 341 342 343 344 345 346 347 348 349 350 351 352 353 354 355 356 357 358 359 360 361 362 363 364 365 366 367 368 369 370 371 372 373 374 375 376 377 378 379 380 381 382 383 384 385 386 387 388 389 390 391 392 393 394 395 396 397 398 399 400 401 402 403 404 405 406 407 408 409 410 411 412 413 414 415 416 417 418 419 420 421 422 423 424 425 426 427 428 429 430 431 432 433 434 435 436 437 438 439 440 441 [Next] |
